Stockholders’ Deficit (Tables)

12 Months Ended

Dec. 31, 2023

Equity [Abstract]

Schedule of Stockholders’ Deficit

The following table summarizes the activity in the Company’s various classes of preferred stock included in Stockholders’ Deficit for the years ended December 31, 2023 and 2022:

	Series H				Series L				Series M				Series N						Series O						Series P				Total
	Shares		Amount		Shares		Amount		Shares		Amount		Shares			Amount			Shares			Amount			Shares		Amount		Shares			Amount
Balance December 31, 2022		10	$	-		250,000	$	2,500		20,810	$	208		2,900		$	29			8,685		$	87			10,195	$	102		292,600		$	2,926
Conversions of Series N Preferred Stock into common stock		-		-		-		-		-				(496	)		(5	)		-			-			-		-		(496	)		(5	)
Conversions of Series O Preferred Stock into common stock		-		-		-		-		-		-		-			-			(535	)		(5	)		-		-		(535	)		(5	)
Balance December 31, 2023		10	$	-		250,000	$	2,500		20,810	$	208		2,404		$	24			8,150		$	82			10,195	$	102		291,569		$	2,916

	Series H				Series F						Series L				Series M				Series N						Series O						Series P				Total
	Shares		Amount		Shares			Amount			Shares		Amount		Shares		Amount		Shares			Amount			Shares			Amount			Shares		Amount		Shares			Amount
Balance December 31, 2021		10	$	-		1,750,000		$	17,500			250,000	$	2,500		20,810	$	208		5,936		$	59			9,900		$	99			8,545	$	85		2,045,201		$	20,451
Conversion of Series F Preferred Stock into common stock		-		-		(1,750,000	)		(17,500	)		-		-		-		-		-			-						-			-		-		(1,750,000	)		(17,500	)
Issuances of Series P Preferred Stock		-		-		-			-			-		-		-		-		-			-			-			-			1,650		17		1,650			17
Conversions of Series N Preferred Stock into common stock		-		-		-			-			-		-		-				(3,036	)		(30	)		-			-			-		-		(3,036	)		(30	)
Conversions of Series O Preferred Stock into common stock		-		-		-			-			-		-		-		-		-			-			(1,215	)		(12	)		-		-		(1,215	)		(12	)
Balance December 31, 2022		10	$	-		-		$	-			250,000	$	2,500		20,810	$	208		2,900		$	29			8,685		$	87			10,195	$	102		292,600		$	2,926

Schedule of Stock Option Activity

	Number of options		Weighted- average exercise price		Weighted- average contractual term (years)
Outstanding at December 31, 2021		26	$	2,992,125		4.33
Granted		-
Expired		-
Outstanding at December 31, 2022		26	$	2,992,125		3.37
Granted		-
Expired		-
Outstanding at December 31, 2023		26	$	2,992,125		2.37
Exercisable at December 31, 2023		26	$	2,992,125

Schedule of Stock Option Outstanding and Exercisable

The following table summarizes information with respect to stock options outstanding and exercisable by employees and directors at December 31, 2023:

Options outstanding										Options vested and exercisable
Exercise price		Number outstanding		Weighted average remaining contractual life (years)		Weighted average exercise price		Aggregate intrinsic value		Number vested		Weighted average exercise price		Aggregate intrinsic value
$	10,000,000		5		2.25	$	10,000,000	$	-		5	$	10,000,000	$	-
$	5,000,000		5		2.25	$	5,000,000		-		5	$	5,000,000		-
$	269,580		8		2.33	$	269,580		-		8	$	269,580		-
$	80,906		8		2.54	$	80,906		-		8	$	80,906		-
			26		2.37	$	2,992,125	$	–		26	$	2,992,125	$	-

Schedule of Warrants Activity

The following summarizes the information related to the number of shares of common stock issuable under outstanding warrants during the years ended December 31, 2023 and 2022:

	Number of Shares of Common Stock Issuable for Warrants			Weighted average exercise price
Balance at December 31, 2021		54,280,658		$	1.43
Issuance of warrants		-			-
Increase in number of shares of common stock issuable under warrants during the period as a result of down round provisions		511,312,671,643			-
Expiration of warrants		(33,601,211	)		(0.9141	)
Balance at December 31, 2022		511,333,351,090		$	0.00009
Issuance of warrants		-			-
Expiration of warrants		(1	)		(794,998	)
Balance at December 31, 2023		511,333,351,089		$	0.00009